Skip to main navigation Skip to search Skip to main content

MRI with magnetic nanoparticles monitors downstream anti-angiogenic effects of mTOR inhibition

Research output: Contribution to journal › Article › peer-review

Abstract

Purpose: To study the effect of mammalian target of rapamycin (mTOR) inhibition on angiogenesis with magnetic resonance imaging (MRI) using magnetic iron oxide nanoparticles (MNP). Procedures: One million CAK-1 renal cell carcinoma cells were subcutaneously implanted into each of 20 nude mice. When tumors reached ∼750 μl, four daily treatment arms began and continued for 4 weeks: rapamycin (mTOR inhibitor) 10 mg/kg/day; sorafenib (VEGF inhibitor) high dose (80 mg/kg/day) and low dose (30 mg/kg/day); and saline control. Weekly MRI (4.7 T Bruker Pharmascan) was performed before and after IV MION-48, a prototype MNP similar to MNP in clinical trials. Vascular volume fraction (VVF) was quantified as ΔR2 (from multi-contrast T2 sequences) and normalized to assumed muscle VVF of 3%. Linear regression compared VVF to microvascular density (MVD) as determined by histology. Results: VVF correlated with MVD (R 2=0.95). VVF in all treatment arms differed fromcontrol (p<0.05) and declined weekly with treatment. VVF changes with rapamycin were similar to high-dose sorafenib. Conclusion: This study demonstrates noninvasive, in vivo anti-angiogenic monitoring using MRI of mTOR inhibition.

Original languageEnglish (US)
Pages (from-to)314-320
Number of pages7
JournalMolecular Imaging and Biology
Volume13
Issue number2
DOIs
StatePublished - Apr 2011
Externally publishedYes

Funding

Acknowledgements. The authors would like to acknowledge grant support from the Dana Farber Renal Spore where Dr. Ross, received funding to support this work from a career development award. In addition, the authors would like to acknowledge funding support from the AstraZeneca Pharmaceuticals, Inc. where Dr. Guimaraes received funding to support part of this work. Lastly, the authors would like to acknowledge Claire Kaufman and Carlos Rangel for technological support in imaging and data analysis

Funders
AstraZeneca

    Keywords

    • Angiogenesis
    • MRI
    • Magnetic nanoparticle imaging
    • Magnetic resonance imaging
    • Renal cell cancer
    • Ultrasmall superparamagnetic iron oxide nanoparticle
    • mTOR

    ASJC Scopus subject areas

    • Oncology
    • Radiology Nuclear Medicine and imaging
    • Cancer Research

    Fingerprint

    Dive into the research topics of 'MRI with magnetic nanoparticles monitors downstream anti-angiogenic effects of mTOR inhibition'. Together they form a unique fingerprint.

    Cite this